Skip to main content

Table 9 Percentage of OCT4, SOX2 and Nanog positive cells values of SH-SY5Y tumors

From: Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma

Stem cell marker

Treatment modality

% Expression of positive cells (p value)

OCT4

AZ

63 ± 0.35 (p < 0.05)

MS-275

37 ± 0.85 (p < 0.001)

AZ + MS-275

18 ± 0.45 (p < 0.05)

SOX2

AZ

68 ± 0.60 (p < 0.01)

MS-275

39 ± 0.50 (p < 0.009)

AZ + MS-275

18 ± 0.46 (p < 0.002)

Nanog

AZ

89 ± 0.60 (p < 0.01)

MS-275

46 ± 0.45 (p < 0.01)

AZ + MS-275

30 ± 0.76 (p < 0.01)

  1. Table 9 shows the percentage of SH-SY5Y tumors by AZ (40 mg/kg), MS-275 (20 mg/kg) and AZ + MS-275 (40 + 20 mg/kg) treatments (14D)